版本:
中国

BRIEF-Can-Fite's phase III acrobat trial in rheumatoid arthritis approved by institutional review board

April 25 Can Fite Biopharma Ltd

* Can-Fite's phase III acrobat trial in rheumatoid arthritis approved by institutional review board

* Can-Fite to conduct investigator meeting in Europe with approximately 100 doctors from participating clinical sites Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐